Neptune & Acasti File Section 337 Complaint on Omega-3 Oil from Krill
Neptune Technologies & Bioresources and its subsidiary Acasti Pharma filed a Section 337 complaint at the International Trade Commission Jan. 29, alleging that ten companies are importing and selling omega-3 extracts that infringe its patents. The products at issue are extracts of omega-3 fatty acids from Antarctic krill. Neptune says the ten companies are infringing on its patents related to the extraction and purification process of the “krill oil.” The company is requesting limited exclusion and cease and desist orders against all respondents. The complaint proposed the following as respondents:
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
- Aker BioMarine AS, Norway
- Aker BioMarine Antarctic USA, Inc.
- Aker BioMarine Antarctic AS, Norway
- Enzymotec Limited, Israel
- Enzymotec USA, INC.
- Olympic Seafood AS, Norway
- Olympic Biotec Ltd., New Zealand
- Avoca, Inc., U.S.
- Rimfrost USA, LLC., U.S.
- Bioriginal Food & Science Corp.
Email ITTNews@warren-news.com for a copy of the complaint.
(D/N 2936, Received 01/29/13)